NCT05558527 The Social Regulation of Threat-related Vigilance and Arousal
| NCT ID | NCT05558527 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nevada, Reno |
| Condition | Psychological Trauma, Historical |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2025-12-18 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2025-12-18 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine the effects of social support on threat vigilance and arousal using eye tracking. We will also test the moderating effects of trauma and discrimination history.
Eligibility Criteria
Inclusion Criteria: * In a stable romantic relationship for 6 months or more * Normal vision or corrected-to-normal vision * Fluent in English Exclusion Criteria: * If vision is corrected-to-normal, needs to use hard contact lenses, bifocal contact lenses, or glasses * Experienced a traumatic event within the past 4 weeks
Contact & Investigator
Cynthia L Lancaster, PhD
PRINCIPAL INVESTIGATOR
University of Nevada, Reno
Frequently Asked Questions
Who can join the NCT05558527 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Psychological Trauma, Historical. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05558527 currently recruiting?
Yes, NCT05558527 is actively recruiting participants. Contact the research team at kyliebaer@unr.edu for enrollment information.
Where is the NCT05558527 trial being conducted?
This trial is being conducted at Reno, United States.
Who is sponsoring the NCT05558527 clinical trial?
NCT05558527 is sponsored by University of Nevada, Reno. The principal investigator is Cynthia L Lancaster, PhD at University of Nevada, Reno. The trial plans to enroll 45 participants.